Nuvectis Pharma, Inc. (NVCT)
22.00
+0.62
(+2.90%)
USD |
NASDAQ |
Sep 18, 16:00
22.03
+0.03
(+0.14%)
After-Hours: 20:00
Nuvectis Pharma Total Return Level : 22.00 for Sept. 18, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 18, 2026 | 22.00 |
| September 17, 2026 | 21.38 |
| September 16, 2026 | 21.87 |
| September 15, 2026 | 21.92 |
| September 14, 2026 | 23.35 |
| September 11, 2026 | 23.99 |
| September 10, 2026 | 22.49 |
| September 09, 2026 | 22.78 |
| September 08, 2026 | 23.99 |
| September 04, 2026 | 24.49 |
| September 03, 2026 | 24.37 |
| September 02, 2026 | 23.92 |
| September 01, 2026 | 23.06 |
| August 31, 2026 | 22.73 |
| August 28, 2026 | 23.73 |
| August 27, 2026 | 25.19 |
| August 26, 2026 | 25.00 |
| August 25, 2026 | 25.89 |
| August 24, 2026 | 23.87 |
| August 21, 2026 | 23.56 |
| August 20, 2026 | 23.35 |
| August 19, 2026 | 23.33 |
| August 18, 2026 | 20.91 |
| August 17, 2026 | 19.08 |
| August 14, 2026 | 18.96 |
| Date | Value |
|---|---|
| August 13, 2026 | 19.23 |
| August 12, 2026 | 19.54 |
| August 11, 2026 | 19.41 |
| August 10, 2026 | 18.88 |
| August 07, 2026 | 18.95 |
| August 06, 2026 | 18.83 |
| August 05, 2026 | 19.26 |
| August 04, 2026 | 20.10 |
| August 03, 2026 | 21.60 |
| July 31, 2026 | 21.52 |
| July 30, 2026 | 22.76 |
| July 29, 2026 | 20.69 |
| July 28, 2026 | 19.82 |
| July 27, 2026 | 19.54 |
| July 24, 2026 | 19.31 |
| July 23, 2026 | 20.15 |
| July 22, 2026 | 19.29 |
| July 21, 2026 | 19.08 |
| July 20, 2026 | 18.03 |
| July 17, 2026 | 19.14 |
| July 16, 2026 | 18.60 |
| July 15, 2026 | 19.59 |
| July 14, 2026 | 18.29 |
| July 13, 2026 | 18.44 |
| July 10, 2026 | 18.35 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Decoy Therapeutics, Inc. | 2.78 |
| Opus Genetics, Inc. | 5.18 |
| Faeth Therapeutics, Inc. | 34.50 |
| Unicycive Therapeutics, Inc. | 4.80 |
| ACADIA Pharmaceuticals, Inc. | 27.29 |